000 01408 a2200397 4500
005 20250514164138.0
264 0 _c20040831
008 200408s 0 0 eng d
022 _a1420-4096
024 7 _a10.1159/000075533
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKalousová, M
245 0 0 _aAdvanced glycation end products in clinical nephrology.
_h[electronic resource]
260 _bKidney & blood pressure research
_c2004
300 _a18-28 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAmyloidosis
_xetiology
650 0 4 _aArteriosclerosis
_xetiology
650 0 4 _aClinical Medicine
650 0 4 _aDiabetes Mellitus
_xmetabolism
650 0 4 _aGlycation End Products, Advanced
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aNephrology
650 0 4 _aReceptor for Advanced Glycation End Products
650 0 4 _aReceptors, Immunologic
_xmetabolism
650 0 4 _aRenal Dialysis
_xadverse effects
650 0 4 _aRenal Insufficiency
_xmetabolism
650 0 4 _aRenal Replacement Therapy
650 0 4 _aUremia
_xcomplications
700 1 _aZima, T
700 1 _aTesar, V
700 1 _aStípek, S
700 1 _aSulková, S
773 0 _tKidney & blood pressure research
_gvol. 27
_gno. 1
_gp. 18-28
856 4 0 _uhttps://doi.org/10.1159/000075533
_zAvailable from publisher's website
999 _c14411585
_d14411585